DONZELLI ELISABETTA

Ruolo:
Tecnica – amministrativa
Settore scientifico disciplinare:
Malattie odontostomatologiche (MED/28)
Telefono:
Stanza:
  • U08, Piano: 1, Stanza: 1024

Pubblicazioni

  • Segmani, I., D'Aprile, C., Cherchi, L., Pozzi, E., Chiorazzi, A., Canta, A., et al. (2026). Thymoquinone Is Effective in Painful Paclitaxel-Induced Peripheral Neuropathy Without Compromising Anticancer Activity. BIOMOLECULES, 16(9) [10.3390/biom16091282]. Dettaglio

  • Naghshbandieh, A., D'Aprile, C., Donzelli, E., Rodriguez Menendez, V., Meregalli, C., Miloso, M., et al. (2026). Chemotherapy Effect on Human iPSC-Derived Sensory Neurons. In 79° Congresso Nazionale SIAI (pp.132-132). Dettaglio

  • Squarzoni, A., Scuteri, A., Donzelli, E., Rodriguez-Menendez, V., Cavaletti, G. (2026). Neuroprotective in vitro effects of histone deacetylase 6–selective inhibitor SW-100 toward oxaliplatin-derived toxicity. MOLECULAR PHARMACOLOGY, 108(7) [10.1016/j.molpha.2026.100137]. Dettaglio

  • Segmani, I., Cherchi, L., Pozzi, E., Chiorazzi, A., Canta, A., Alberti, P., et al. (2025). THYMOQUINONE AS A POSSIBLE NEUROPROTECTIVE AGENT AGAINST PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY. In Abstracts of the Fifteenth Annual Meeting of the Associazione italiana per lo studio del Sistema Nervoso Periferico (ASNP) 12 to 14 June 2025 Lecce, Italy (pp.44-44). Dettaglio

  • Squarzoni, A., Ette, M., Boleslav, B., Donzelli, E., Scuteri, A., Cavaletti, G., et al. (2024). Pharmacodynamic Drug-Drug Interaction Between Oxaliplatin and HDAC Inhibitors in Colorectal Cancer Cell Lines. Intervento presentato a: Population Approach Group Europe (PAGE) Meeting 2024, Rome, Italy. Dettaglio